Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 51

1.

Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

Beara-Lasic L, Pillinger MH, Goldfarb DS.

Int J Nephrol Renovasc Dis. 2010;3:1-10. Epub 2010 Feb 9.

PMID:
21694922
[PubMed]
Free PMC Article
2.

Urate-lowering therapy for gout: focus on febuxostat.

Love BL, Barrons R, Veverka A, Snider KM.

Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Review.

PMID:
20500048
[PubMed - indexed for MEDLINE]
3.

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A.

Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Review.

PMID:
19846027
[PubMed - indexed for MEDLINE]
Free Article
4.

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal.

Stevenson M, Pandor A.

Pharmacoeconomics. 2011 Feb;29(2):133-40. doi: 10.2165/11535770-000000000-00000. Review.

PMID:
21155617
[PubMed - indexed for MEDLINE]
5.

Febuxostat: a selective xanthine-oxidase/xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout.

Ernst ME, Fravel MA.

Clin Ther. 2009 Nov;31(11):2503-18. doi: 10.1016/j.clinthera.2009.11.033. Review.

PMID:
20109996
[PubMed - indexed for MEDLINE]
6.

Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout.

Yu KH.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):69-75. Review.

PMID:
19075968
[PubMed - indexed for MEDLINE]
7.

Update on emerging urate-lowering therapies.

Chohan S, Becker MA.

Curr Opin Rheumatol. 2009 Mar;21(2):143-9. doi: 10.1097/BOR.0b013e328325bd94. Review. Erratum in: Curr Opin Rheumatol. 2010 Jan;22(1):106.

PMID:
19339925
[PubMed - indexed for MEDLINE]
8.

Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Fam AG.

Curr Rheumatol Rep. 2001 Feb;3(1):29-35. Review.

PMID:
11177768
[PubMed - indexed for MEDLINE]
9.

Febuxostat: a new treatment for hyperuricaemia in gout.

Edwards NL.

Rheumatology (Oxford). 2009 May;48 Suppl 2:ii15-ii19. doi: 10.1093/rheumatology/kep088. Review.

PMID:
19447778
[PubMed - indexed for MEDLINE]
Free Article
10.

A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout.

Chao J, Terkeltaub R.

Curr Rheumatol Rep. 2009 Apr;11(2):135-40. Review.

PMID:
19296886
[PubMed - indexed for MEDLINE]
11.

Update on gout: new therapeutic strategies and options.

Terkeltaub R.

Nat Rev Rheumatol. 2010 Jan;6(1):30-8. doi: 10.1038/nrrheum.2009.236. Review.

PMID:
20046204
[PubMed - indexed for MEDLINE]
12.

Emerging therapies in the long-term management of hyperuricaemia and gout.

Stamp LK, O'Donnell JL, Chapman PT.

Intern Med J. 2007 Apr;37(4):258-66. Review.

PMID:
17388867
[PubMed - indexed for MEDLINE]
13.

The challenges of gout management in the elderly.

Stamp LK, Jordan S.

Drugs Aging. 2011 Aug 1;28(8):591-603. doi: 10.2165/11592750-000000000-00000. Review.

PMID:
21812496
[PubMed - indexed for MEDLINE]
14.

Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent.

Assadi F.

J Nephrol. 2013 Jul-Aug;26(4):624-8. doi: 10.5301/jn.5000204. Epub 2012 Aug 30. Review.

PMID:
22941874
[PubMed - indexed for MEDLINE]
15.

Pegloticase for treating refractory chronic gout.

George RL Jr, Sundy JS.

Drugs Today (Barc). 2012 Jul;48(7):441-9. doi: 10.1358/dot.2012.48.7.1813475. Review.

PMID:
22844655
[PubMed - indexed for MEDLINE]
16.

Febuxostat.

Hair PI, McCormack PL, Keating GM.

Drugs. 2008;68(13):1865-74. Review.

PMID:
18729537
[PubMed - indexed for MEDLINE]
17.

Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review.

Curiel RV, Guzman NJ.

Semin Arthritis Rheum. 2012 Oct;42(2):166-78. doi: 10.1016/j.semarthrit.2012.03.013. Epub 2012 May 3. Review.

PMID:
22560299
[PubMed - indexed for MEDLINE]
18.

Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.

Bruce SP.

Ann Pharmacother. 2006 Dec;40(12):2187-94. Epub 2006 Nov 28. Review.

PMID:
17132810
[PubMed - indexed for MEDLINE]
19.

[Treatment of gout].

Dubost JJ, Mathieu S, Soubrier M.

Rev Med Interne. 2011 Dec;32(12):751-7. doi: 10.1016/j.revmed.2011.02.007. Epub 2011 Mar 5. Review. French.

PMID:
21382654
[PubMed - indexed for MEDLINE]
20.

Uricase and other novel agents for the management of patients with treatment-failure gout.

Sundy JS, Hershfield MS.

Curr Rheumatol Rep. 2007 Jun;9(3):258-64. Review.

PMID:
17531181
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk